Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1066)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
704
Price
$513.40
Total Value
$361.43K
Shares Held After
332,103
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
642
Price
$512.47
Total Value
$329.01K
Shares Held After
332,807
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
494
Price
$511.58
Total Value
$252.72K
Shares Held After
333,449
% of Holdings
0.1%
OMEROS CORP (OMER)
HANISH ARNOLD C — Director
Shares
5,000
Price
$19.02
Total Value
$95.08K
Shares Held After
0
% of Holdings
100.0%
OMEROS CORP (OMER)
HANISH ARNOLD C — Director
Shares
5,000
Price
$18.88
Total Value
$94.38K
Shares Held After
5,000
% of Holdings
50.0%
MediWound Ltd. (MDWD)
Hess Shmuel — COO&Chief Commercial Officer
Shares
1,979
Price
$13.13
Total Value
$25.98K
Shares Held After
0
% of Holdings
100.0%
MediWound Ltd. (MDWD)
Hess Shmuel — COO&Chief Commercial Officer
Shares
1,979
Price
$12.72
Total Value
$25.17K
Shares Held After
0
% of Holdings
100.0%
REGENXBIO Inc. (RGNX)
Ciongoli Gregory Austin — Director
Shares
53,407
Price
$9.36
Total Value
$499.68K
Shares Held After
118,035
% of Holdings
45.2%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
250
Price
$7.60
Total Value
$1.90K
Shares Held After
14,453
% of Holdings
1.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
251
Price
$7.35
Total Value
$1.84K
Shares Held After
14,704
% of Holdings
1.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
4
Price
$7.58
Total Value
$30.32
Shares Held After
14,708
% of Holdings
0.0%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
8,931
Price
$1.39
Total Value
$12.41K
Shares Held After
610,842
% of Holdings
1.5%
Alzamend Neuro, Inc. (ALZN)
AULT MILTON C III — Director
Shares
2,000
Price
$1.56
Total Value
$3.12K
Shares Held After
0
% of Holdings
100.0%
Oric Pharmaceuticals, Inc. (ORIC)
Piscitelli Dominic — Chief Financial Officer
Shares
77,000
Price
$13.69
Total Value
$1.05M
Shares Held After
69,828
% of Holdings
52.4%
PRECIGEN, INC. (PGEN)
KINDLER JEFFREY B — Director
Shares
185,000
Price
$7.44
Total Value
$1.38M
Shares Held After
17,100
% of Holdings
91.5%
Adaptive Biotechnologies Corp (ADPT)
OWEN KATEY EINTERZ — Director
Shares
9,615
Price
$26.00
Total Value
$249.99K
Shares Held After
78,639
% of Holdings
10.9%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
5,626
Price
$73.18
Total Value
$411.71K
Shares Held After
1,349,094
% of Holdings
0.4%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
6,874
Price
$72.74
Total Value
$500.01K
Shares Held After
1,354,720
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
4,508
Price
$20.03
Total Value
$90.30K
Shares Held After
223,657
% of Holdings
2.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
51
Price
$13.96
Total Value
$711.96
Shares Held After
141,002
% of Holdings
0.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
249
Price
$13.96
Total Value
$3.48K
Shares Held After
680,948
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
18,300
Price
$2.97
Total Value
$54.35K
Shares Held After
2,840,635
% of Holdings
0.6%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
2,000
Price
$5.33
Total Value
$10.66K
Shares Held After
2,000
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
Park Kimberly — Director
Shares
26,685
Price
$122.55
Total Value
$3.27M
Shares Held After
0
% of Holdings
100.0%
OMEROS CORP (OMER)
HANISH ARNOLD C — Director
Shares
5,000
Price
$18.53
Total Value
$92.63K
Shares Held After
0
% of Holdings
100.0%
MediWound Ltd. (MDWD)
Hess Shmuel — COO&Chief Commercial Officer
Shares
1,865
Price
$13.00
Total Value
$24.25K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$521.48
Total Value
$20.86K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$520.62
Total Value
$208.25K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
476
Price
$519.35
Total Value
$247.21K
Shares Held After
324,883
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,790
Price
$518.35
Total Value
$927.85K
Shares Held After
325,359
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,516
Price
$517.49
Total Value
$1.82M
Shares Held After
327,149
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,128
Price
$516.70
Total Value
$582.83K
Shares Held After
330,665
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,591
Price
$515.41
Total Value
$820.01K
Shares Held After
331,793
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
559
Price
$514.64
Total Value
$287.68K
Shares Held After
333,384
% of Holdings
0.2%
REGENXBIO Inc. (RGNX)
Ciongoli Gregory Austin — Director
Shares
49,196
Price
$9.14
Total Value
$449.71K
Shares Held After
64,628
% of Holdings
76.1%
Monopar Therapeutics (MNPR)
RIOUX PATRICE — Acting Chief Medical Officer
Shares
1
Price
$111.26
Total Value
$111.26
Shares Held After
5,065
% of Holdings
0.0%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
590
Price
$113.84
Total Value
$67.17K
Shares Held After
7,396
% of Holdings
7.4%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
602
Price
$112.93
Total Value
$67.98K
Shares Held After
7,986
% of Holdings
7.0%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
1,098
Price
$111.84
Total Value
$122.80K
Shares Held After
8,588
% of Holdings
11.3%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
700
Price
$110.65
Total Value
$77.45K
Shares Held After
9,686
% of Holdings
6.7%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
615
Price
$109.56
Total Value
$67.38K
Shares Held After
10,386
% of Holdings
5.6%
Monopar Therapeutics (MNPR)
Tsuchimoto Kim R — Director
Shares
485
Price
$108.83
Total Value
$52.78K
Shares Held After
11,001
% of Holdings
4.2%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Dietz Thomas John — Director
Shares
20,000
Price
$1.72
Total Value
$34.40K
Shares Held After
132,500
% of Holdings
13.1%
Immatics N.V. (IMTX)
PERCEPTIVE ADVISORS LLC — Director
Shares
863,060
Price
$8.69
Total Value
$7.50M
Shares Held After
11,246,516
% of Holdings
7.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
14,569
Price
$7.06
Total Value
$102.86K
Shares Held After
4,318,348
% of Holdings
0.3%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
14,569
Price
$7.06
Total Value
$102.86K
Shares Held After
4,318,348
% of Holdings
0.3%
Adlai Nortye Group Ltd. (ANL)
Ye Xiaofeng — CFO
Shares
5,667
Price
$14.25
Total Value
$80.75K
Shares Held After
147,757
% of Holdings
3.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
100
Price
$7.50
Total Value
$750.00
Shares Held After
13,953
% of Holdings
0.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
250
Price
$7.52
Total Value
$1.88K
Shares Held After
14,203
% of Holdings
1.8%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
46,000
Price
$0.04
Total Value
$1.84K
Shares Held After
445,400
% of Holdings
10.3%
Showing 151–200 of 1066 transactions (page 4 of 22)